Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

What we are studying

The main purpose of this clinical trial is to see if a new topical cream (topical ABI-1968 cream) can treat High-grade squamous intraepithelial lesions (HSIL) in the anus safely and effectively.

Who is Eligible

  • All Genders
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 27+

Eligibility Criteria

  • Never been vaccinated against HPV
  • Must not be pregnant and must agree not to become pregnant during the study
  • No HSIL treatment in the past six months
  • Must have HSIL present (we will determine this)

What is involved

  • Visits to the clinic for screening and then once a week for first month
  • Once every two weeks for the next two months at which time study is completed
  • Blood draws
  • Anal swabs
  • Pregnancy tests
  • Study procedure (High Resolution Anoscopy)
  • Application of cream


You will be paid $75 for each visit until study completion

Contact Information

Study Coordinator
Keisa Williamson
[email protected]
Principal Investigator
Luis F. Barroso, MD

силикатный кирпич цена

купить магистерскую работу в Екатеринбурге

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.